OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of ...

Eko Health announced today that the American Medical Association issued a Category III CPT code for its Sensora platform.

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

The Samsung Galaxy Ring is a debut for the brand, but also an extension in its lineup of wearables. It can track certain ...

The Fibrosis-4 Index (FIB-4) is used to identify adults who don’t have viral ... “Thus, current guidelines focusing on early ...

The solid electrolyte interface (SEI) in lithium-ion (Li-ion) batteries is essential for calculating a battery’s capacity and ...

Fourth Frontier has achieved a crucial milestone with the FDA's clearance of the Frontier X Plus, a single-lead ECG monitor. Positioned to enhance heart health monitoring, this wearable device ...

Atrial arrhythmias were found in 26% of patients with sickle cell disease (SCD), with a significant association with stroke history. Early detection and treatment of atrial arrhythmias may help ...

Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the ...

Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11%, a study shows.